Chaya Moskowitz, PhD

Attending Biostatistician

Share
Print
Share
Print
Chaya Moskowitz, Attending  Biostatistician

Office Phone

646-888-8232

Education

University of Washington

Current Research Interests

Dr. Moskowitz’s primary collaborations are with investigators in the cancer survivorship and radiology research communities. She also provides statistical support to the MSK Exercise Oncology Service. She is involved in studies researching issues pertinent to survivors of cancer, particularly survivors of pediatric cancers. Much of this work has been focused on the epidemiological study of late effects of treatment for pediatric cancers, but she has also served as the lead statistician for randomized intervention studies in this population. She works with radiology investigators on the design and analysis of a variety of studies assessing different imaging modalities, potential imaging biomarkers, and different imaging-based response metrics in cancer clinical trials. Her primary research interest focuses on identifying and evaluating different methods and modalities for identifying childhood cancer survivors at high risk of breast cancer.

Publications

Selected peer-reviewed publications:

  1. Moskowitz CS, Pepe MS. Quantifying and comparing the accuracy of binary biomarkers when predicting a failure time outcome. Stat Med 2004; 23:1555-1570.
  2. Moskowitz CS, Pepe MS. Comparing the predictive values of diagnostic tests: sample size and analysis for paired study designs. Clinical Trials. 2006 June; 3:272-279.
  3. Moskowitz CS, Jia X, Schwartz LH, Gönen M. A simulation study to evaluate the impact of the number of lesions measured on response assessment. Eur J Cancer. 2009 Jan; 45(2): 300-310.
  4. Moskowitz CS, Chou JF, Wolden SL, Bernstein JL, Malhotra J, Friedman DN, Mubdi NZ, Leisenring WM, Stovall M, Hammond S, Smith SA, Henderson TO, Boice JD, Hudson MM, Diller LR, Bhatia S, Kenney LB, Neglia JP, Begg CB, Robison LL, Oeffinger KC. Breast cancer after chest radiation therapy for childhood cancer. J Clin Oncol. 2014 Jul 20;32(21):2217-23.
  5. Moskowitz CS, Chou JF, Sklar CA, Barnea D, Ronckers CM, Friedman DN, Neglia JP, Turcotte L, Howell RM, Henderson TO, Armstrong GT, Leisenring WM, Robison LL, van Leeuwen FE, Pike MC, Oeffinger KC. Radiation-associated breast cancer and gonadal hormone exposure: a report from the Childhood Cancer Survivor Study. Br J Cancer. 2017 Jul 11;117(2):290-299.

Visit PubMed for a full listing of Chaya Moskowitz’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Chaya Moskowitz discloses the following relationships and financial interests:

  • Radiological Society of North America
    Provision of Services

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures